The specific interventions examined were: isoniazid at a dose of 10 mg/kg per day; isoniazid and rifampin at a dose of 10 mg/kg per day, with both these regimes administered for 2 months; erythromycin at doses ranging from 30 to 50 mg/kg per day for 1 month; and a single streptomycin instillation. The control groups received placebo or no treatment.
The specific interventions examined were: isoniazid at a dose of 10 mg/kg per day; isoniazid and rifampin at a dose of 10 mg/kg per day, with both these regimes administered for 2 months; erythromycin at doses ranging from 30 to 50 mg/kg per day for 1 month; and a single streptomycin instillation. The control groups received placebo or no treatment.
Participants included in the review
All of the participants were infants at the time of presentation with ipsilateral lymph node enlargement after BCG vaccination.
Outcomes assessed in the review
The outcome measures examined differed according to the type of adenitis. The primary outcome measure for nonsuppurative BCG adenitis was the frequency of the development of suppuration among treatment and control participants. For suppurative BCG adenitis, the frequency of spontaneous drainage and the time taken to heal were considered the primary outcome measures.
How were decisions on the relevance of primary studies made?
The authors did not state how the papers were selected for the review, or how many reviewers performed the selection.
Assessment of study quality
The articles identified were assessed according to the following criteria: allocation concealment, blinding of the outcome assessment, and blinding to other patient (age of presentation) and disease characteristics (size of lymph nodes). The amount of variation in the therapeutic interventions and outcome measures was also assessed. Two authors assessed the papers independently. There were no further details of how the validity assessment was conducted, or how any disagreements between the authors were resolved. 
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